Synthesis of a silanediol within a peptide backbone can yield a low nanomolar inhibitor of metallo- and aspartic proteases. We have developed an efficient synthetic route to these nonhydrolyzable dipeptide analogs, with full control of stereochemistry. Progress in extending the application of these inhibitors to serine protease such as Chymotrypsin will be presented.